Based on these data and the potential change in follow-up care, the HPV mRNA assay should not be used for a primary screening tool for cervical cancer.
The HR-HPV types covered by the nonavalent HPV vaccine had similar clearance rates to HR-HPV types not included, and women infected with multiple anogenital HR-HPV types had lower rates of clearance than women infected with only 1 type.
Adolescent consent may help minimize delays in vaccination and reduce the overall incidence of cervical, oropharyngeal, and anal cancers.
A bundled intervention including communication skills training and performance feedback may improve human papillomavirus vaccination.
For adolescents, a health care professional HPV vaccine communication intervention is associated with improved HPV vaccine series initiation and completion.
Study confirms HPV16 as an important determinant of high-grade lesions and supports its place as a priority for anal cancer prevention.
Deintensification of treatment from chemoradiotherapy to one modality may compromise safety in patients with human papillomavirus (HPV)+ stage 1 or 2 oropharyngeal cancer.
The limitations of herd protection for vaccine-type HPV was examined in a recent study.
Study was the first to examine the geographical variation of seminal HPV prevalence, showing a relatively high prevalence in fertility clinic attendees when compared to the general population.
For patients with HPV-associated cancers, there are large disparities in survival based on sex, race, and age.
Successive negative HPV and cytology co-testing is linked decrease risks of cervical cancer.
Findings inform further refinement of cervical cancer screening algorithms for vaccinated populations.
Incidence of juvenile-onset respiratory papillomatosis declined with the introduction of a HPV vaccination program.
Many US physicians recommended primary HPV testing for women of all ages, contrary to guidelines which limit this screening approach to women ≥25 years old.
The incidence of HPV-related oropharyngeal squamous cell carcinoma has increased in men dramatically and that increase is projected to continue until 2060.
Rajesh T. Gandhi, MD, discusses management of coinfections, including HPV and sexually transmitted infections, in people with HIV.
From 2009-2010 to 2013-2014, there was a decrease in the prevalence of vaccine-type human papillomavirus among unvaccinated young women, which suggests they are beginning to benefit from herd immunity.
Inadvertent administration of the quadrivalent HPV vaccine during periconception or pregnancy was not associated with additional risk to mothers and their infants.
Human papillomavirus vaccine initiation rates are low among young cancer survivors.
Patients with HPV-associated oropharyngeal squamous cell carcinoma have higher 5-year overall survival rates after surgery.
Women with HIV are more likely to experience progressive cervical changes.
Survivors of anal cancer have an elevated risk of HPV-related second primary malignancies.
Maternal education, Hispanic ethnicity, and provider recommendations are associated with parental intent to vaccinate adolescents against HPV.
Two rather than 3 doses of the human papillomavirus vaccine is enough to protect against genital warts in preteens and teens.
The human papillomavirus (HPV) vaccine offers a higher degree of protection in oral HPV infections.
Self-persuasion method facilitates HPV vaccination better than external persuasion in low literacy, safety-net settings.
HPV vaccine has the potential to reverse the epidemic and prevent thousands of cancers in the United States each year.
The American Society of Clinical Oncology issued new recommendations based on 4 levels of resource settings on human papillomavirus vaccination for cervical cancer prevention.
After a 30-minute educational session with high school seniors, basic knowledge of human papillomavirus and the benefits of HPV vaccination significantly increased.
Distant metastases rates are up in patients with HPV-positive oropharyngeal cancer, who actively smoke or have T4 tumors.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Generic HIV Medicines: Boon or Bust?
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- Pregnancy May Be Independently Associated With Prolonged Detection of Zika Virus RNA
- It Costs $2.2 Billion a Year to Treat Antibiotic Resistance
- Tricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis C
- Fingerstick Point-of-Care Test Allows for Single-Visit HCV Diagnoses
- Clostridium difficile Infection in the Intensive Care Setting
- Combating Medically Important Antibiotic Use in Food-Producing Animals
- Religious Exemptions vs Mandatory Vaccinations: An Expert Perspective
- 2018 Vaccination Schedule: Adults
- Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared
- Glecaprevir/Pibrentasvir Highly Efficacious for HCV/HIV Coinfection
- Fluoroquinolone Use May Increase Risk for Aortic Aneurysm and Dissection
- Reduced Risk of Hepatocellular Carcinoma in DAA-Treated HCV Infection
- Paracetamol Overuse During Cold and Flu Season